| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |